AstraZeneca saw the highest growth of 108% in patent filings in January and 131% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 108% and grants by 96%. GlobalData’s DataBook provides a comprehensive analysis of AstraZeneca‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

AstraZeneca has been focused on protecting inventions in United States(US) with 71 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 22% filings and 18% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where AstraZeneca is filings its patents. Among the top granted patent authorities, AstraZeneca has 18% of its grants in United States(US), 16% in Australia(AU) and 8% in European Patent Office(EPO).

F. Hoffmann-La Roche and Pfizer could be the strongest competitors for AstraZeneca

In terms of grant share, AstraZeneca stands in sixth position among its competitors. F. Hoffmann-La Roche and Pfizer secured the top positions according to recent patent publication data.

Patents related to rare diseases and climate change lead AstraZeneca's portfolio

AstraZeneca has the highest number of patents in rare diseases followed by, climate change and healthtech. For rare diseases, nearly 40% of patents were filed and 39% of patents were granted in Q1 2024.

Paroxysmal nocturnal hemoglobinuria related patents lead AstraZeneca portfolio followed by hypertension, and congestive heart failure (heart failure)

AstraZeneca has highest number of patents in paroxysmal nocturnal hemoglobinuria followed by hypertension, congestive heart failure (heart failure), type 1 diabetes (juvenile diabetes), and type 2 diabetes. For paroxysmal nocturnal hemoglobinuria, nearly 1% of patents were filed and 2% of patents were granted in Q1 2024.

For comprehensive analysis of AstraZeneca's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.